Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating recombinant interleukin-21 in combination with sorafenib for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens [Phase 2]
This Phase 2 clinical trial investigated the combination of capecitabine and interferon-Alpha in patients with metastatic renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib [Phase 1, Phase 2]
This update covers a Phase 1/2 clinical trial evaluating autologous vaccination for stage 4 renal cell carcinoma in combination with Sunitin…
-
CLINICAL_TRIALS trial_result · 2009-04-14Clinical Trial Update: A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of thalidomide and capecitabine in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R) [Phase 2]
A Phase 2 trial evaluating sunitinib with or without bevacizumab in first-line metastatic renal cell carcinoma was terminated; results were …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) [Phase 2]
Phase 2 clinical trial update on PF-3512676 (CPG 7909) for patients who completed an oncology study using the drug. The document notes that …
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer [Phase 1]
Phase 1 study evaluating Interleukin-21 for metastatic malignant melanoma and metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-26Clinical Trial Update: Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial evaluating whether adding interleukin-2 to sorafenib improves outcomes as first-line therapy in advanced renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2009-02-12Clinical Trial Update: CPG 7909 in Patients Wih Stage IV Renal Cell Cancer [Phase 1, Phase 2]
Pfizer-sponsored CPG 7909 was evaluated in a Phase 1/2 trial for stage IV renal cell carcinoma and the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 3]
A Phase 3 trial comparing interferon alfa-2b with or without thalidomide in patients with metastatic or unresectable kidney cancer has compl…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC [Phase 2]
Phase 2 clinical trial evaluating a mixture of G, C, and S for renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-11Clinical Trial Update: A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients [Phase 1]
A completed Phase I trial evaluating the combination of bevacizumab and sunitinib in patients with metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2008-09-15Clinical Trial Update: Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment [Phase 2]
Phase 2 study evaluating continuation of panitumumab in patients who previously benefited and tolerated the drug has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Chemotherapy in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update evaluating chemotherapy in patients with metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma [Phase 2]
Phase II trial of CAP-232 in refractory metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of oral recombinant human lactoferrin in patients with renal cell carcinoma has been comp…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma [Phase 2]
A Phase 2 study evaluating the safety, tolerability and efficacy of E7070 in patients with renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
This document covers the natural history and pathobiology of endolymphatic sac tumors in Von Hippel-Lindau disease and describes a prospecti…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer [Phase 1]
This Phase I study evaluated continuous intravenous infusion of PSC 833 (valspodar) with vinblastine in patients with metastatic renal cance…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [Phase 1]
A completed Phase I study of oral COL-3 (NSC-683551), an matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer, …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
Phase I study of infusional paclitaxel combined with the P-glycoprotein antagonist PSC 833 (valspodar) in patients with various cancers; the…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial evaluated the combination of capecitabine and GTI-2040 for renal cell carcinoma, including metastatic case…
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
This update describes a phase 1/2 clinical trial evaluating the combination of temsirolimus and sunitinib in adults with advanced renal cell…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: ATN-161 in Advanced Renal Cell Cancer [Phase 2]
A Phase 2 trial of ATN-161 for advanced renal cell carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: A Study of ABT-751 in Patients With Renal Cell Cancer [Phase 2]
A Phase 2 study of ABT-751 in renal cell carcinoma has completed.